314 related articles for article (PubMed ID: 25756579)
1. Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes.
Park JY; Rha SW; Choi B; Choi JW; Ryu SK; Kim S; Noh YK; Choi SY; Akkala RG; Li H; Ali J; Xu S; Ngow HA; Lee JJ; Lee GN; Kim J; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim E; Park CG; SeogSeo H; Oh DJ
Int J Cardiol; 2015 Apr; 184():502-506. PubMed ID: 25756579
[TBL] [Abstract][Full Text] [Related]
2. Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians.
Park JY; Rha SW; Choi BG; Choi SY; Choi JW; Ryu SK; Lee SJ; Kim S; Noh YK; Akkala RG; Li H; Ali J; Kim JB; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
Yonsei Med J; 2016 Jan; 57(1):180-6. PubMed ID: 26632399
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction.
Choi JY; Choi CU; Hwang SY; Choi BG; Jang WY; Kim DY; Kim W; Park EJ; Lee S; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Chae SC; Kim YJ; Cho MC; Kim CJ; Kim HS; Jeong MH;
Am J Cardiol; 2018 Sep; 122(6):922-928. PubMed ID: 30217375
[TBL] [Abstract][Full Text] [Related]
4. New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.
Choi JY; Choi CU; Choi BG; Park Y; Kang DO; Jang WY; Kim W; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Jeong MH; Chae SC; Seong IW; Yoon CH; Cha KS; Oh SK;
BMC Pharmacol Toxicol; 2021 Feb; 22(1):11. PubMed ID: 33541430
[TBL] [Abstract][Full Text] [Related]
5. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
Seo WW; Seo SI; Kim Y; Yoo JJ; Shin WG; Kim J; You SC; Park RW; Park YM; Kim KJ; Rhee SY; Park M; Jin ES; Kim SE
Cardiovasc Diabetol; 2022 May; 21(1):82. PubMed ID: 35606846
[TBL] [Abstract][Full Text] [Related]
6. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
[TBL] [Abstract][Full Text] [Related]
7. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
[TBL] [Abstract][Full Text] [Related]
8. Selective ß1-Blockers Are Not Associated With New-onset Diabetes Mellitus in Hypertensive Patients.
Park Y; Choi BG; Rha SW; Baek MJ; Ryu YG; Choi SY; Byun JK; Shim MS; Mashaly A; Li H; Jang WY; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
J Cardiovasc Pharmacol; 2018 Jan; 71(1):38-45. PubMed ID: 29286954
[TBL] [Abstract][Full Text] [Related]
9. Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial.
Lee JH; Kang HJ; Kim HS; Sohn DW; Oh BH; Park YB
Am J Cardiovasc Drugs; 2013 Oct; 13(5):343-51. PubMed ID: 23728830
[TBL] [Abstract][Full Text] [Related]
10. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
11. Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes.
González-Lleó AM; Sánchez-Hernández RM; Plana N; Ibarretxe D; Rehues P; Ribalta J; Llop D; Wägner AM; Masana L; Boronat M
Cardiovasc Diabetol; 2024 Jan; 23(1):4. PubMed ID: 38172901
[TBL] [Abstract][Full Text] [Related]
12. Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
Ong KL; Waters DD; Messig M; DeMicco DA; Rye KA; Barter PJ
Am J Cardiol; 2014 May; 113(10):1593-8. PubMed ID: 24666618
[TBL] [Abstract][Full Text] [Related]
13. Impact of Statin Use on Development of New-Onset Diabetes Mellitus in Asian Population.
Rha SW; Choi BG; Seo HS; Park SH; Park JY; Chen KY; Park Y; Choi SY; Shim MS; Kim JB; Park T; Park J; Lee JJ; Park EJ; Park SH; Choi JY; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Oh DJ
Am J Cardiol; 2016 Feb; 117(3):382-7. PubMed ID: 26732422
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.
Borovac JA; Leth-Olsen M; Kumric M; D'Amario D; Schwarz K; Glavas D; Bozic J
Eur J Clin Pharmacol; 2022 Jan; 78(1):111-126. PubMed ID: 34423376
[TBL] [Abstract][Full Text] [Related]
15. Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study.
Lee HS; Chae W; Sung MJ; Keum J; Jo JH; Chung MJ; Park JY; Park SW; Song SY; Park EC; Nam CM; Jang SI; Bang S
J Clin Endocrinol Metab; 2023 May; 108(6):1338-1347. PubMed ID: 36548964
[TBL] [Abstract][Full Text] [Related]
16. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
Giustino G; Colantonio LD; Brown TM; Carson AP; Dai Y; Farkouh ME; Monda KL; Muntner P; Rosenson RS
Cardiovasc Drugs Ther; 2018 Oct; 32(5):453-461. PubMed ID: 30078077
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of allowable pancreatic resection rate depending on preoperative risk factors for new-onset diabetes mellitus after distal pancreatectomy.
Izumo W; Higuchi R; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Pancreatology; 2020 Oct; 20(7):1526-1533. PubMed ID: 32855059
[TBL] [Abstract][Full Text] [Related]
18. A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
Kim JB; Song WH; Park JS; Youn TJ; Park YH; Kim SJ; Ahn SG; Doh JH; Cho YH; Kim JW
PLoS One; 2021; 16(1):e0245481. PubMed ID: 33481866
[TBL] [Abstract][Full Text] [Related]
19. Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.
Park JB; Jung JH; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW
Trials; 2017 Oct; 18(1):501. PubMed ID: 29078817
[TBL] [Abstract][Full Text] [Related]
20. To study the effect of high dose Atorvastatin 40mg versus 80mg in patients with dyslipidemia.
Agrawal D; Manchanda SC; Sawhney JPS; Kandpal B; Jain R; Mehta A; Mohanty A; Passey R; Makhija A; Sharma MK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S8-S12. PubMed ID: 30595326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
